Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,025 public trials 3,714 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

NCT06930859

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Novartis Investigative Site Kaluga, Russia
  • Novartis Investigative Site Pskov, Russia
  • Novartis Investigative Site Ryazan, Russia
  • Novartis Investigative Site Saint Petersburg, Russia
View all 42 locations
View Trial Details
Recruiting

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117) Sun City, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120) Tucson, Arizona, United States
  • Medvin Clinical Research - Riverside ( Site 5115) Riverside, California, United States
  • Cohen Medical Centers ( Site 5111) Thousand Oaks, California, United States
View all 50 locations
View Trial Details
Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

NCT06926868

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Local Institution - 0303 Hot Springs, Arkansas, United States
  • Helios Clinical Research Cerritos, California, United States
  • Local Institution - 0307 Cerritos, California, United States
  • Local Institution - 0308 Cerritos, California, United States
View all 295 locations
View Trial Details
Recruiting

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

NCT07100106

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSF Helen Diller Family CCC San Francisco, California, United States
View all 61 locations
View Trial Details
Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

NCT07647328

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Marietta, Georgia, United States
  • Research Site Evanston, Illinois, United States
View all 89 locations
View Trial Details
Recruiting

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

NCT04855435

Conditions
Advanced Solid Tumor, Cutaneous Melanoma, Eye Diseases, +21 more
Locations
  • Herlev and Gentofte Hospital, Center for Cancer Research Herlev, Denmark
  • Institut Catalá de Oncologia - Hospital Duran i Reynals. Barcelona, Spain
  • Fundacion Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (FJD) Madrid, Spain
  • Centro Integral Oncológico Clara Campal (CIOCC) Madrid, Spain
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details

Related conditions